Monmouth Retina Consultants

Rupan Trikha, M.D.

Monmouth Retina Consultants NJ | Dr. Trikha

Dr. Trikha holds his medical doctorate from the University of Medicine and Dentistry of New Jersey, New Jersey Medical School. Dr. Trikha served as the Chief Resident of Ophthalmology at Geisinger Medical Center in Danville, Pennsylvania and is a Rutgers University of New Brunswick alumnus, where he studied for both his undergraduate and graduate degrees.

Article by Dr. Trikha Retina Today - Why Small-Gauge Endoscopy Should Not Be Overlooked (May/June 2017)


 

Education

Medical Degree | 2003
University of Medicine and Dentistry of New Jersey
New Jersey Medical School, Newark, NJ
Medical Doctorate

Graduate Program | 1998
Microbiology and Molecular Genetics
Rutgers University, New Brunswick, NJ

Undergraduate | 1998
Rutgers College
Rutgers University New Brunswick, NJ
Bachelor of Arts

Medical Training

Vitreo-Retinal Disease and Surgery Fellowship | July 2007 – June 2009
University of California, Davis Medical Center
Department of Ophthalmology
Sacramento, CA

Ophthalmology Residency | July 2004 – June 2007
Geisinger Medical Center
Department of Ophthalmology
Danville, PA

Medicine Internship | July 2003 – June 2004
University of Medicine and Dentistry - University Hospital
Department of Medicine
Newark, NJ

Employment History

Associate Physician | July 2011 – Present
Monmouth Retina Consultants
Little Silver, NJ 07739

Associate Physician | August 2009 – June 2011
Geisinger Medical Center
Danville, PA

Attending Physician | July 2007 – June 2009
Veterans Administration Medical Center
Department of Ophthalmology
Mather, CA 95655

Teaching Assistant | Aug 1998 – Jan 1999
Biology 101
Rutgers University
New Brunswick, NJ

Honors & Awards

  • Patient Satisfaction Award, Geisinger Medical Center | 2010
  • Chief Resident of Ophthalmology, Geisinger Medical Center, Danville PA | 2006-2007
  • Student Director of Neuroscience Summer Research Program, New Jersey Medical School, Newark, NJ | 2000

Certification & Licensure

  • New Jersey State Medical License | 2011
  • Pennsylvania State Unrestricted Medical License | 2011
  • American Board of Ophthalmology Certification | 2008
  • California State Medical License | 2010
  • USMLE Steps I, II, III – Passed | 2004

International Projects

Uveitis and Retinal disease | December 2005
Department of Ophthalmology
Aravind Eye Hospital, Tamil Nadu, India

Emergency Medicine | March 2003
Karl Heusner Memorial Hospital
Belize city, Belize

Research Publications

Trikha R, Morse LS, Zawadzki RD, Werner JS, Park SP. Ten-year Follow-up of Eyes Treated with Stereotactic-Fractionated External Beam Radiation for Neovascular Age-related Macular Degeneration. Retina 2011;31(7):1303-1315.

Eric K Chin, Rupan Trikha, Lawrence S Morse, Robert J Zawadzki, John S Werner, Susanna S Park Optical Coherence Tomography Findings of Exophytic Retinal Capillary Hemangiomas of the Posterior Pole. Ophthalmic Surg Lasers Imaging. 2010;Mar 9:1-5

Trikha R, Yeung CC, Modjtahedi SP, Telander DG. Evaluation of 25-Gauge and 20-Gauge Vitrectomy on cell viability and diagnostic yield for B-cell lymphoma in culture using flow cytometry. Retina 2010;30:1505-1510

Rupan Trikha, Isabella Thomas, Robert A. Schwartz. Poison ivy dermatitis. Dermatologia Kliniczna 2003, 5(1):7-10.

Chapter Publications

Rupan Trikha, Nicole Beharry and David G. Telander. Chapter Publication April 4, 2012: Small Gauge Pars Plana Vitrectomy, Vitrectomy, Dr. Zongming Song (Ed.), ISBN: 978-953-51-0546-6, InTech Publications.

Arunagiri G, Trikha R. Chapter 188: Corneal abrasions, contusions, and lacerations. Roy and Fraunfelder’s Current Ocular Therapy, 6th edition. Elsevier health science 2008.

Abstracts

  • Chin EK, Trikha R, Morse L, Zawadzki RJ, Werner JS, Park SS. Optical coherence tomography findings of exophytic retinal capillary hemangiomas of the posterior pole. Association for Research in Vision and Ophthalmology annual meeting, Fort Lauderdale, FL, May 7, 2009.
  • Trikha R, Yeung CC, Modjtahedi SP, Telander DG. Evaluation of 25 Gauge and 20 Gauge Vitrectomy on cell viability and diagnostic yield for B-cell lymphoma in culture using flow cytometry. Accepted for poster presentation, Association for Research in Vision and Ophthalmology annual meeting, Fort Lauderdale, FL, May 7, 2009.
  • Trikha R, Morse LS, Ryu J, Telander DG, Park SS. Long-term follow up on patients treated with stereotactic external beam radiation for exudative age-related macular degeneration. Poster Presentation, Combined American Academy of Ophthalmology and European Society of Ophthalmology meeting, Atlanta, GA, November 9, 2008.
  • Trikha R, Morse LS, Zawadzki RJ, Ryu J, Telander DG, Choi SS, Werner JS, Park SS. Long-term follow-up and High Resolution Fourier-domain Optical Coherence Tomographic Imaging of Eyes Treated with Stereotactic Fractionated External Beam Radiation for Neovascular Age-related Macular Degeneration. Paper presentation, American Society of Retina Specialists annual meeting, Maui, HI, October 12, 2008.
  • Trikha R, Morse LS, Ryu J, Telander DG, Park SS. Long-term follow up on patients treated with stereotactic external beam radiation for exudative age-related macular degeneration. Poster Presentation, Association for Research in Vision and Ophthalmology annual meeting, Fort Lauderdale, FL, April 2008.
  • Trikha R, Marks SJ. Retinal boxcarring in a case of hemolytic anemia with cold agglutinin disease. Video Presentation, American Academy of Ophthalmology annual meeting 2007.
  • Trikha R, Guruswami A. Multiple cranial nerve palsies in a case of Neuroborriliosis. Poster Presentation, North American Neuro-ophthalmology society (NANOS) annual meeting 2005.

Clinical Trials

  • Abicipar Pegol (DARPin) versus Lucentis in the Treatment of Wet Age Related Macular Degeneration
    PRINCIPAL INVESTIGATOR: 2015
    Multicenter, randomized, double-masked, parallel group, active-controlled study to assess the safety and efficacy of abicipar compared with ranibizumab in patients with neovascular AMD.
  • AZD3293 for the treatment of Alzheimers.
    The AMARANTH Study.
    CO – INVESTIGATOR: 2014 – Present.
    A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
  • Lucentis for Age Related Macular Degeneration
    HORIZON / Extension of MARINA Study. CO – INVESTIGATOR: 2007 – 2009 An Open-Label, Multicenter Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects with Subfoveal Choroidal Neovascular Membrane (CNV) Secondary to Age-Related Macular Degeneration (AMD) Who Have Completed the Treatment Phase of a Genentech-Sponsored Ranibizumab Study (HORIZON FVF3426g).
  • Lucentis for Age Related Macular Degeneration
    DNA Repository Study in Association with Study FVF3426g (An Open-Label, Multicenter Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects with Choroidal Neovascularization [CNV] Secondary to Age-Related Macular Degeneration [AMD] Who Have Completed the Treatment Phase of a Genentech-Sponsored Ranibizumab Study). CO – INVESTIGATOR: 2007 – 2009
  • Anacortave Acetate for Age Related Macular Degeneration
    Anacortave Acetate Risk-Reduction Trial (AART). CO – INVESTIGATOR: 2007 - 2009 An Evaluation of Efficacy and Safety of Posterior Juxtascleral Administrations of Anecortave Acetate for Depot Suspension (15 mg or 30 mg) versus Sham Administration in Patients (Enrolled in Study "A" or Study "B") at Risk for Developing Sight-Threatening Choroidal Neovascularization (CNV) Due to Exudative Age-Related Macular Degeneration (AMD).
  • Posurdex for Retinal Vein Occlusion
    POSURDEX for CRVO (009). CO – INVESTIGATOR: 2007 – 2009 A Six-Month, Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial (With Six-Month Open-Label Extension) to Assess the Safety and Efficacy of 700 ºg and 350 ºg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator System in the Treatment of Patients with Macular Edema Following Central Retinal Vein Occlusion or Branch Retinal Vein Occlusion (Protocol 206207-009).
  • AREDS II Vitamins for Age Related Macular Degeneration
    AREDS II Vitamin Study. CO – INVESTIGATOR: 2007 – 2009 Age-Related Eye Disease Study 2 (AREDS2): A Multi-center, Randomized Trial of Lutein, Zeaxanthin, and Omega-3 Long-Chain Polyunsaturated Fatty Acids (Docosahexaenoic Acid [DHA] and Eicosapentaenoic Acid [EPA]) in Age-Related Macular Degeneration
  • POSURDEX for Diabetic Retinal Edema (009). CO – INVESTIGATOR: 2007 - 2009 A 3-Year, Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial to Assess the Safety and Efficacy of 700 ºg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator System in the Treatment of Patients with Diabetic Macular Edema (Protocol 206207-010)
  • Proton Beam with Lucentis for Age Related Macular Degeneration. CO – INVESTIGATOR: 2007 – Present Phase I Pilot, Open Label, Prospective Observational Study of Safety and Tolerability of Lucentis Combined with Proton Beam Radiation in Treating Exudative Age-Related Macular Degeneration.
  • Lucentis versus Laser for Diabetic Macular Edema
    RISE STUDY. CO – INVESTIGATOR: 2007 – 2009 A Phase III, Double-Masked, Multicenter, Randomized, Sham Injection-Controlled Study of the Efficacy and Safety of Ranibizumab Injection compared to Laser Photocoagulation in Subjects with Clinically Significant Macular Edema with Center Involvement Secondary to Diabetes Mellitus
  • Lucentis versus Avastin for Treatment of Wet Age Related Macular Degeneration
    Comparison of AMD Treatment Trials (CATT): Lucentis-Avastin Trial. CO – INVESTIGATOR: 2007 – 2009 Clinical trial comparing efficacy of bevacizumab versus ranibizumab for exudative age-related macular degeneration with PRN and monthly dosing.
  • OCT Comparison Study
    Comparison of Optic Nerve and Macular Thickness and MorphologyCO – INVESTIGATOR: 2007 - 2009 Comparison Among Commercially Available Fourier-domain Optical Coherence Tomography Units.
  • Lucentis for Diabetic Macular Edema
    DNA Repository Substudy in Association with RISE Study: CO – INVESTIGATOR: 2007 – 2009 Ranibizumab Study FVF4170g (A Phase III, Double-Masked, Multicenter, Randomized, Sham Injection-Controlled Study of the Efficacy and Safety of Ranibizumab Injection in Subjects with Clinically Significant Macular Edema with Center Involvement Secondary to Diabetes Mellitus).
  • Macugen for Age Related Macular Degeneration
    LEVEL Study: CO – INVESTIGATOR: 2007 – 2009 A Phase IV, Open label, Multi-Center Trial of Maintenance Intravitreous Injections of Macugen® (Pegaptanib Sodium) Given Every 6 Weeks for 48 Weeks in Subjects with Subfoveal Neovascular Age-Related Macular Degeneration (AMD) Initially Treated with a Modality Resulting in Maculopathy Improvement. Study EOP1023
  • CNTF3 for Retinitis Pigmentosa: CO – INVESTIGATOR: 2007 – 2009 A Phase II/III Study of Encapsulated Human NTC-201 Cell Implants Releasing Ciliary Neurotrophic Factor (CNTF) for Participants with Retinitis Pigmentosa Using Visual Acuity as the Primary Outcome - Protocol Designation CNTF-3
  • CNTF4 for Retinitis Pigmentosa: CO – INVESTIGATOR: 2007 – 2009 A Phase II/III Study of Encapsulated Human NTC-201 Cell Implants Releasing Ciliary Neurotrophic Factor (CNTF) for Participants with Retinitis Pigmentosa Using Visual Field Sensitivity as the Primary Outcome - Protocol Designation CNTF-4

Selected Platform Presentations

Emergency Medicine Grand Rounds: Ophthalmic Emergencies. Department of Emergency Medicine, Newark Beth Israel Medical Center, Newark, NJ. June 3, 2015

Oral Medications in Ophthalmology, Annual Lecture, New Jersey Academy of Optometry. Jumping Brook Country Club, Nepture, NJ. August 8, 2014.

Keynote speaker, Joseph C Toland Excellence in Education Lecture. Age-related Macular Degeneration, A New Era in Management for Optometrists. Salus University, Elkins Park, PA. May 4, 2014.

Age-related macular degeneration: Diagnosis, prevention, and treatment. Danville Community Center, Danville, PA, August 19, 2009.

Comparison of 25G and 20G Vitrectomy on Diagnostic Yield for B-Cell Lymphoma. University of California, Davis Medical Center, Annual Napa Valley Symposium, Napa Valley, CA, May 15, 2009.

Long-term follow-up and High Resolution Fourier-domain Optical Coherence Tomographic Imaging of Eyes Treated with Stereotactic Fractionated External Beam Radiation for Neovascular Age-related Macular Degeneration. Paper presentation, American Society of Retina Specialists annual meeting, Maui, HI, October 2008. Also presented at University of California, Davis Medical Center, Annual Napa Valley Symposium, Napa Valley, CA, April 27, 2008.

Stargardts Disease. Retinal Degeneration Grand Rounds, University of California Davis Medical Center, Sacramento, CA, April 3, 2009.

Retinoblastoma. Grand Rounds Presentation, 2008. University of California, Davis Medical Center, Sacramento, CA, April 2008

Update on Focal Treatment for Retinoblastoma. Tumor Board Conference 2008. University of California, Davis Medical Center

Syphilis Chorioretinitis. Brazil Telemedicine Grand Rounds 2008. University of California, Davis Medical Center, Sacramento, CA, November 2007.

Recurrent Conjunctival Melanosis, Shields Ocular Oncology Conference 2007. Geisinger Medical Center

Retinopathy of Prematurity, Ophthalmology Grand Rounds 2007 Geisinger Medical Centre.

Eye Care in India, Aravind Eye Hospital, Tamil Nadu, India 2006. Geisinger Medical Center

Case Report: Cone-Rod dystrophy. Retina Conference 2005. Geisinger Medical Center.

Case Report: Unusual Case of Neuroborriliosis. Resident Research Day 2005. Geisinger Medical Center

Volunteer and Community Service

Parker Family Health Center | 2012 – Present
Diabetic Eye Exams
Shrewsbury, NJ

Shifa Community Clinic | 2008
Volunteer Ophthalmologist
Sacramento, CA

Neil G. Shastri foundation | 2001 – 2007
Board member, Board of Directors
A charity foundation in honor of a World Trade Center victim

Chic Chat Foundation | 2002
Finance hair.
Charity Organization for the personal development of boarding-home girls in Morristown, NJ

Professional Membership

  • American Academy of Ophthalmology | 2004 - Present
  • American Society of Retina Specialists | 2008 - Present
  • Association for Research in Vision and Ophthalmology | 2007 - 2009